Vitreous vascular endothelial growth factor level during gestation

Archives of Gynecology and Obstetrics

Volumn 281, Issue 3, 2010, Pages 417-421

  Türkçüoǧlu, Ilgin ^a   Türkçüoflu, Peykan ^a   Karabulut, Aysun Bay ^a   Taşar, Ahmet ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Gestation; Level; Plasma; VEGF; Vitreous

Indexed keywords

VASCULOTROPIN 165;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PUERPERIUM; RABBIT; STORAGE TEMPERATURE; SUPERNATANT; VITREOUS BODY;

ANIMALS; FEMALE; PREGNANCY; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 77950629407     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1144-7     Document Type: Article

References (37)

1. Reynolds LP, Redmer DA. (1995) Utero-placental vascular development and placental function. J Anim Sci 73:1839-1851
2. Torry DS, Leavenworth J, Chang M, Maheshwari V, Groesch K, Ball ER, Torry RJ. (2007) Angiogenesis in implantation. J Assist Reprod Genet 24:303-315 (Pubitemid 47593603)
3. Kadyrov M, Kosanke G, Kingdom J, Kaufmann P. (1998) Increased fetoplacental angiogenesis during first trimester in anaemic women. Lancet 352:1747-1749 (Pubitemid 28534958)
4. Reynolds LP, Redmer DA. (2001) Angiogenesis in the placenta. Biol Reprod 64:1033-1040
5. Klagsbrun M, D'Amore PA. (1991) Regulators of angiogenesis. Annu Rev Physiol 53:217-239
6. Breier G, Damert A, Plate KH, Risau W. (1997) Angiogenesis in embryos and ischemic diseases. Thromb Haemost 78:678-683 (Pubitemid 27289326)
7. Iruela-Arispe ML, Dvorak HF. (1997) Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 78:672-677
8. Senger DR, Van deWater L, Brown LF, Nagy JA, Yeo KT, Teo TK et al. (1993) Vascular permeability factor. (VPF, VEGF) in tumor biology. Cancer Metastasis 12:303-324
9. Klein BE, Moss SE, Klein R. (1987) Longitudinal measure of glycemic control and diabetic retinopathy. Diabetes Care 10:273-277 (Pubitemid 17083567)
10. Barnett AH. (1993) Origin of the microangiopathic changes in diabetes. Eye 7:218-222
11. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Caldwell RW. (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 19:442-455 (Pubitemid 37536961)
12. Rosenblatt BJ, Benson WE. (2004) Diabetic retinopathy. In: YanoV M, Duker JS. (eds) Ophthalmology, 2nd edn. Mosby Inc, St. Louis, p 877
13. Klein BE, Moss SE, Klein R. (1990) Effect of gestation on progression of diabetic retinopathy. Diabetes Care 13:34-40 (Pubitemid 20024727)
14. Davidorf FH, Chambers RB. (1993) Diabetic retinopathy during gestation. Clin Perinatol 20:571-581
15. Cherwek DH, Hopkins MB, Thompson MJ, Annex BH, Taylor DA. (2000) Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia. Am J Physiol Heart Circ Physiol 279:932-938
16. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. (1998) A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59:1540-1548 (Pubitemid 28549874)
17. Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, Kaufmann S, Walters CE, Jackson A, Eves P, Linton G, Keen J, Walker JJ, Selby PJ. (1998) Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod 4:377-386 (Pubitemid 28228534)
18. Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM. (1997) Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3:2187-2190 (Pubitemid 28133134)
19. van der Flier M, Coenjaerts FE, Mwinzi PN, Rijkers E, Ruyken M, Scharringa J, Kimpen JL, Hoepelman AI, Geelen SP. (2005) Antibody neutralization of vascular endothelial growth factor. (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis. J Neuroimmunol 160:170-177 (Pubitemid 40248606)
20. Bosio PM, Wheeler T, Anthony F, Conroy R, O'herlihy C, McKenna P. (2001) Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 184:146-152 (Pubitemid 32141657)
21. Evans PW, Wheeler T, Anthony FW, Osmond C. (1998) A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Hum Reprod 13:1057-1062 (Pubitemid 28239220)
22. Ludwig M, Jelkmann W, Bauer O, Diedrich K. (1999) Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod 14:2437-2441 (Pubitemid 29473906)
23. Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G, Genazzani AR. (1998) Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 70:560-564 (Pubitemid 28435646)
24. Abramov Y, Barak V, Nisman B, Schenker JG. (1997) Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 67:261-265 (Pubitemid 27052182)
25. Sone H, Okuda Y, Kawakami Y, Kondo S, Hanatani M, Matsuo K, Suzuki H, Yamashita K. (1996) Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture. Life Sci 59:21-25 (Pubitemid 26198125)
26. Swiatek-De Lange M, StampX A, Hauck SM, Zischka H, Gloeckner CJ, Deeg CA, UeYng M. (2007) Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells. Glia 55:1061-1073 (Pubitemid 47066746)
27. Kaaja R, Sjöberg L, Hellsted T, Immonen I, Sane T, Teramo K. (1996) Long-term effects of gestation on diabetic complications. Diabet Med 13:165-169 (Pubitemid 26075526)
28. Sunness JS. (1988) The pregnant woman's eye. Surv Ophthalmol 32:219-238
29. Chaturvedi N, Stephenson JM, Fuller JH. (1995) The relationship between gestation and long-term maternal complications in the EURODIAB IDDM Complications Study. Diabet Med 12:494-499
30. Rosenn B, Miodovnik M, Kranias G, Khoury J, Combs CA, Mimouni F, Siddiqi TA, Lipman MJ. (1992) Progression of diabetic retinopathy in gestation: association with hypertension in gestation. Am J Obstet Gynecol 166:1214-1218
31. Lauszus F, Klebe JG, Bek T. (2000) Diabetic retinopathy in gestation during tight metabolic control. Acta Obstet Gynecol Scand 79:367-370 (Pubitemid 30261143)
32. Larinkari J, Laatikainen L, Ranta T, Mörönen P, Pesonen K, Laatikainen T. (1982) Metabolic control and plasma hormone levels in relation to retinopathy in diabetic gestation. Diabetologia 22:327-332 (Pubitemid 12154517)
33. Rosenn BM, Miodovnik M. (2000) Medical complications of diabetes mellitus in gestation. Clin Obstet Gynecol 43:17-31 (Pubitemid 30414145)
34. Chen CH, Chen SC. (1987) Evidence of the presence of a specific vascular endothelial growth factor in fetal bovine retina. Exp Cell Res 169:287-295
35. Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, D'Amore PA. (1995) Hypoxic induction of endothelial cell growth factors in retinal cells: identiWcation and characterization of vascular endothelial growth factor. (VEGF) as the mitogen. Mol Med 1:182-193
36. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. (1994) Vascular endothelial growth factor in ocular Xuid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487 (Pubitemid 24356306)
37. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT. (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450 (Pubitemid 24307211)